Piotr Podolec

Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries

Guy De Backer, Piotr Jankowski, Kornelia Kotseva et al. · Atherosclerosis · 2019 · 369 citations · Full text

Medicine, Cardiology, Internal Medicine +14

RETRACTED: Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

Gérald Simonneau, Andrea Maria D’Armini, Peter F. Fedullo et al. · The Lancet Respiratory Medicine · 2017 · 264 citations

Medicine, Internal Medicine, Pharmacotherapy +11

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

Deepak L. Bhatt, Philippe Gabríel Steg, Shamir R Mehta et al. · The Lancet · 2019 · 210 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

Clinical and echocardiographic assessment of pregnant women with valvular heart diseases—maternal and fetal outcome

Agata Leśniak‐Sobelga, Wiesława Tracz, Magdalena Kostkiewicz et al. · International Journal of Cardiology · 2004 · 145 citations · Full text

Medicine, Cardiology, Obstetrics +17

Altered Fibrin Clot Structure/Function in Patients With Cryptogenic Ischemic Stroke

Anetta Undas, Piotr Podolec, Krystyna Zawilska et al. · Stroke · 2009 · 132 citations

Medicine, Neurosurgery, Cerebrovascular Neurosurgery +16